drugset / Trial / NCT02920385
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.
NaSingle-groupOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the influence of oral semaglutide on the pharmacokinetics (the exposure of the trial drug in the body) of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of semaglutide administered orally in healthy subjects.
Timeline
- Start
- 2016-10-10
- Primary completion
- 2017-04-26
- Completion
- 2017-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levothyroxine | Other / unclassified | — | Oral |
| Subject | SNAC | Unknown | — | Oral |
| Subject | Semaglutide | Peptide | — | Oral |